In this narrative review, we aim to give an up-to-date perspective on the implications of NLRP3 inflammasome in atherosclerosis by describing their intricate physio-pathological relationship, their known therapeutic pathways and the existence of newer molecules that can modulate atherosclerosis via NLRP3 inflammasome. Here, NLRP3 is linked to atherosclerosis.